Concepedia

Paul A. Renhowe

PA

Statistics

Publications

27

Citations

1.3K

H-Index

19

Active since

1990

Affiliations

Novartis (Switzerland)(Current)

Ironwood Pharmaceuticals (United States)

University of California, Irvine

Omron (Japan)

University of Arizona

Paul A. Renhowe is an author at Novartis (Switzerland) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1990–2021

27

Publications

27

Enantioselective Total Synthesis of (-)-Ptilomycalin A

Larry E. Overman, Michael H. Rabinowitz, Paul A. Renhowe · Journal of the American Chemical Society · 1995 · 209 citations

, , +5

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Paul A. Renhowe, Sabina Pecchi, Cynthia M. Shafer et al. · Journal of Medicinal Chemistry · 2008 · 135 citations · Full text

, , +13

Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors

Savithri Ramurthy, Sharadha Subramanian, Mina Aikawa et al. · Journal of Medicinal Chemistry · 2008 · 76 citations · Full text

, , +13

4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors

Zhi‐Jie Ni, Paul A. Barsanti, Nathan Brammeier et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 71 citations · Full text

, , +7

A new nucleophilic alaninol synthon from serine

Mukund P. Sibi, Paul A. Renhowe · Tetrahedron Letters · 1990 · 65 citations

, , +7

1–5 of 27